s3e05 Unraveling the Mysteries and Empowering Patients in the Long COVID Journey

New York Public Health Now

Dr. Geeta Sood joins Department of Health Commissioner Dr. James McDonald and Executive Deputy Commissioner Johanne Morne to discuss the growing public health concern of Long COVID, highlighting the need for comprehensive care and ongoing research.
They explore the diverse range of symptoms associated with Long COVID, from brain fog to POTS, and the need for a comprehensive, multidisciplinary approach to management and care. The conversation also covers the effects of vaccination and antiviral therapies, such as Paxlovid, in helping to reduce the risk of developing Long COVID after a COVID-19 infection.
The Department of Health will also be holding a Commissioner's Medical Grand Rounds on Long COVID on October 13, 2024 at noon - you must register to attend: https://forms.office.com/g/Eus28gsTfk

If you have an idea for topics we should discuss, please let us know: [e-mail]

บท

1. Welcome & Introduction (00:00:00)

2. Dr. Sood's Background (00:01:55)

3. How was Long COVID first described and is there an agreed-upon definition? (00:03:28)

4. Does someone have to have a positive COVID-19 diagnosis to have Long COVID? (00:04:39)

5. Is Long COVID unique to the United States? (00:06:31)

6. Who seems to be most at risk for developing Long COVID? (00:07:38)

7. What are the usual signs and symptoms of Long COVID? (00:09:21)

8. Am I less likely to get Long COVID if I receive my COVID-19 vaccination? (00:11:27)

9. Does taking antivirals like Paxlovid help prevent Long COVID? (00:12:26)

10. Why is Metformin something people are studying right now? (00:14:41)

11. Do subsequent COVID-19 infections increase the likelihood of Long COVID? (00:15:34)

12. What is the best approach to Long COIVD management? (00:16:26)

13. What are some of the Long COVID areas covered by the Commissioner's Medical Grand Rounds? (00:18:40)

14. Can viewers of the Commissioner's Medical Grand Rounds on Long COVID expect to hear about the latest research developments? (00:19:38)

15. Closing thoughts and resources on Long COVID (00:20:33)

16. Thanks & Farewell (00:21:46)